'Individual patient data' diaporamas de présentation

HORMONOTERAPIA EN CANCER DE MAMA

HORMONOTERAPIA EN CANCER DE MAMA . DR MARCO ANTONIO GARCIA HERNANDEZ R3OM. HORMONOTERAPIA ADYUVANTE.

1.08k views • 73 slides

The patient with alcoholic liver disease in ITU

748 views • 53 slides

Case scenario

An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia. Case scenario.

651 views • 51 slides

Approaching the In Silico Child Jeffrey S. Barrett, PhD, FCP

534 views • 42 slides

EM TREATMENT OF ACUTE STROKE

1.15k views • 34 slides

Using Weibull Model to Predict the Future: ATAC Trial

Using Weibull Model to Predict the Future: ATAC Trial. Anna Osmukhina, PhD Principal Statistician, AstraZeneca 15 April 2010. Survival Analysis. Rate. Example: Exponential Time to Event. Constant hazard. Overall Survival. No disease. Randomization. Death. Events in Early Breast Cancer.

548 views • 32 slides

U.S. Food and Drug Administration

384 views • 22 slides

Putting the Office System in Place

Putting the Office System in Place. Paula Duncan, MD, FAAP Chair, AAP Bright Futures Implementation Advisory Committee . I have no relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in this CME activity.

408 views • 18 slides

A universal model of predictors of outcome was shown to fit all studies

Outcome Predicators for Rate of Cumulative Abstinence Duration from Individual Patient Data across 16 European and U.S. Double-Blind Placebo-Controlled Trials (N =4457). A universal model of predictors of outcome was shown to fit all studies abstinence at the onset of treatment

93 views • 1 slides